Discover 901 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trials in Indianapolis focus on numerous chronic conditions such as lupus, heart disease, and dystrophy. The city’s leading healthcare institutions are actively recruiting participants seeking paid clinical research opportunities as a healthy volunteer, as well as those looking for studies related to a particular health condition to help advance medical knowledge and treatment options in these critical areas.
Filter
2
Filter results
Results: 901
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Indianapolis IN, Plainfield IN, Bowling Green KY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Indianapolis IN, Chicago IL, Ann Arbor MI, St Louis MO,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase 1, Recruiting
Active & Responsive
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer
for
Non Small Cell Lung Cancer
Location: Indianapolis IN, Peoria IL, Nashville TN, Buffalo NY,
Sponsor: Ankyra Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT07027514
Phase 1, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Indianapolis IN, Chicago IL, Ann Arbor MI, St Louis MO,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
for
Alzheimer Disease
Location: Indianapolis IN, Fort Wayne IN, Palos Hills IL,
Sponsor: Alpha Cognition, Inc
Sex: All
Age: 50+
Code: NCT07633470
Phase 4, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
for
Parkinson Disease
Location: Indianapolis IN, Lexington KY, Columbus OH,
Location: Indianapolis IN, Fort Wayne IN, Chesterfield MO,
Sponsor: BioPoly LLC
Sex: All
Age: 30 - 65
Code: NCT06915363
Recruiting
Active & Responsive
Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.
for
Osteomyelitis
Location: Indianapolis IN, Baltimore MD, Oradell NJ, San Diego CA
Sponsor: Biocomposites Ltd
Sex: All
Age: 18+
Code: NCT07270380
Recruiting
Active & Responsive
The Ailliance Post-Market Clinical Study
for
Spinal Deformity, Spinal Degenerative Disorder,
Location: Indianapolis IN, Carmel IN, Bloomington IN,
Sponsor: Medtronic Spinal and Biologics
Sex: All
Age: 18+
Code: NCT05856370
Recruiting
Active & ResponsiveNew
Knee Cartilage Repair Registry
for
Knee Injuries, Joint Surface Knee Lesions
Location: Indianapolis IN, DuBois PA, Washington D.C. DC,
Sponsor: Smith & Nephew, Inc.
Sex: All
Age: 18+
Code: NCT07786207
Recruiting
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Hypertension,
Location: Avon IN, Greenfield IN, Muncie IN, Richmond IN,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07064473
Phase 3, Recruiting
Active & Responsive
Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation
for
Capsular Contracture Associated With Breast Implant,
Location: Indianapolis IN, Chicago IL, St Louis MO, Nashville TN,
Sponsor: C. R. Bard
Sex: Female
Age: 22 - 70
Code: NCT05945329
Recruiting
Active & Responsive
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Carmel IN, La Crosse WI, Dallas TX, Reno NV
Sponsor: Complement Therapeutics
Sex: All
Age: 55+
Code: NCT07392255
Phase 1, Phase 2, Recruiting
Active & Responsive
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
for
Diabetic Retinopathy, Macular Edema
Location: Carmel IN, Charleston WV, Knoxville TN, Johnson City TN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07705555
Phase 3, Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)